183 related articles for article (PubMed ID: 22019080)
1. Common and unique responses to dopamine agonist therapy and deep brain stimulation in Parkinson's disease: an H(2)(15)O PET study.
Bradberry TJ; Metman LV; Contreras-Vidal JL; van den Munckhof P; Hosey LA; Thompson JL; Schulz GM; Lenz F; Pahwa R; Lyons KE; Braun AR
Brain Stimul; 2012 Oct; 5(4):605-15. PubMed ID: 22019080
[TBL] [Abstract][Full Text] [Related]
2. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
[TBL] [Abstract][Full Text] [Related]
3. H(2)(15)O PET responses to deep brain stimulation.
Montgomery EB
Brain Stimul; 2012 Oct; 5(4):657-9. PubMed ID: 22410478
[No Abstract] [Full Text] [Related]
4. Reply to letter to the editor "H(2)(15)O PET responses to deep brain stimulation".
Bradberry TJ; Metman LV; Contreras-Vidal JL; Schulz GM; Braun AR
Brain Stimul; 2013 Jan; 6(1):94-5. PubMed ID: 22410479
[No Abstract] [Full Text] [Related]
5. A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease.
Park HJ; Park B; Kim HY; Oh MK; Kim JI; Yoon M; Lee JD; Chang JW
Yonsei Med J; 2015 May; 56(3):726-36. PubMed ID: 25837179
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
Auffret M; Le Jeune F; Maurus A; Drapier S; Houvenaghel JF; Robert GH; Sauleau P; Vérin M
J Neurol Sci; 2017 Jan; 372():279-287. PubMed ID: 28017228
[TBL] [Abstract][Full Text] [Related]
7. Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT.
Sestini S; Ramat S; Formiconi AR; Ammannati F; Sorbi S; Pupi A
J Nucl Med; 2005 Sep; 46(9):1444-54. PubMed ID: 16157526
[TBL] [Abstract][Full Text] [Related]
8. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
[TBL] [Abstract][Full Text] [Related]
9. Network modulation in the treatment of Parkinson's disease.
Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D
Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713
[TBL] [Abstract][Full Text] [Related]
10. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
[TBL] [Abstract][Full Text] [Related]
11. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.
Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Pinsker MO; Herzog H; Volkmann J; Deuschl G; Fink GR
Brain; 2008 Jan; 131(Pt 1):132-45. PubMed ID: 17977862
[TBL] [Abstract][Full Text] [Related]
12. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
14. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
[TBL] [Abstract][Full Text] [Related]
15. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
[TBL] [Abstract][Full Text] [Related]
16. Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.
Hanssen H; Steinhardt J; Münchau A; Al-Zubaidi A; Tzvi E; Heldmann M; Schramm P; Neumann A; Rasche D; Saryyeva A; Voges J; Galazky I; Büntjen L; Heinze HJ; Krauss JK; Tronnier V; Münte TF; Brüggemann N
Parkinsonism Relat Disord; 2019 Oct; 67():99-104. PubMed ID: 31494048
[TBL] [Abstract][Full Text] [Related]
17. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
Alegret M; Valldeoriola F; Martí M; Pilleri M; Junqué C; Rumià J; Tolosa E
Mov Disord; 2004 Dec; 19(12):1463-9. PubMed ID: 15390065
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
20. Pallidal deep brain stimulation and L-dopa effect on PET motor activation in advanced Parkinson's disease.
Valálik I; Emri M; Lengyel Z; Mikecz P; Trón L; Csókay A; Márián T
J Neuroimaging; 2009 Jul; 19(3):253-8. PubMed ID: 19021848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
